An obesity drug biotech gets buy-in from Eli Lilly, venture firms
Bio Pharma Dive
NOVEMBER 7, 2023
Startup OrsoBio raised $60 million in a Series A round co-led by Longitude Capital and Enavate Sciences, and joined by the pharma’s venture arm.
Tue.Nov 07, 2023
299 
Millions of Women Feel Severe Pain From This Condition. Why Don’t We Talk About It?
AuroBlog - Aurous Healthcare Clinical Trials blog
NOVEMBER 7, 2023
Endometriosis causes physical, sexual and emotional pain. About 190 million people around the globe have endometriosis, including one in 10 American women, but there has historically been a deafening silence about the disease and the pervasive impact it can have on a person’s life.
Join 21,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Biogen, Sage set price of postpartum depression pill at $15,900
Bio Pharma Dive
NOVEMBER 7, 2023
The price is below what some analysts had predicted and significantly less than $34,000 Sage initially set for its earlier postpartum infusion, Zulresso.
TN DCA initiates action against use of diclofenac & aceclofenac in veterinary treatments to control death of vultures
AuroBlog - Aurous Healthcare Clinical Trials blog
NOVEMBER 7, 2023
The Tamil Nadu Drug Control Administration (TN DCA) has initiated action against the use of analgesic and anti-inflammatory drugs, diclofenac and aceclofenac, in veterinary treatments on account of sharp decline in vulture population in the forest areas of the state.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Flagship expands into Asia-Pacific with new Singapore hub
Bio Pharma Dive
NOVEMBER 7, 2023
The biotech company creator hopes its new office will help its portfolio companies grow and strike partnerships in the region.
Cell and gene therapy biotechs face access hurdles in Europe
Pharmaceutical Technology
NOVEMBER 7, 2023
At BIO-Europe 2023, experts said competition from the US and China and proposed European legislation are hurdles for this sector.
Sign up to get articles personalized to your interests!
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
More Trending
FDA warns of hidden drug ingredients in Dr Ergin’s SugarMD
Pharmaceutical Technology
NOVEMBER 7, 2023
Patients who have used the products should consult their healthcare provider and properly discard the product.
Ventyx revises TYK2 drug plans after lackluster study data
Bio Pharma Dive
NOVEMBER 7, 2023
The biotech will terminate studies of its drug in psoriasis and psoriatic arthritis after the “magnitude of efficacy” reported in one was less than Ventyx’s target.
AAO 2023: PULSAR and PHOTON studies provide promising results for AMD and DME
Pharmaceutical Technology
NOVEMBER 7, 2023
These studies evaluated the effectiveness of HD Eylea (aflibercept 8mg) in patients with AMD and patients with DME.
AbbVie, AstraZeneca, Boehringer and more face FTC's ire for 'improper' patent listings
Fierce Pharma
NOVEMBER 7, 2023
Pharma, you were warned. | Only two months after the Federal Trade Commission said it was eying a crackdown on improper patents listed by the FDA, the agency has filed challenges against more than 100 patents in the agency's Orange Book. The companies have 30 days to respond.
AAO 2023: Allgenesis Biotherapeutics presents Phase IIa data of AG-73305 for DME
Pharmaceutical Technology
NOVEMBER 7, 2023
At AAO 2023, results were presented from the Phase IIa trial of Allgenesis’ AG-73305, evaluating its application for the treatment of DME.
Navigating Regulatory Compliance in the Pharmaceutical Industry
Pharma Mirror
NOVEMBER 7, 2023
Navigating regulatory compliance in the pharmaceutical industry is crucial to ensure the safety, efficacy, and quality of pharmaceutical products. The pharmaceutical industry is heavily regulated in most countries to protect public health and to maintain the integrity of the products. Here are some key aspects to consider when navigating regulatory compliance in the pharmaceutical industry: Understanding Regulatory Authorities: Identify the regulatory authorities that govern pharmaceuticals in y
Immuno-oncology: the leading companies in cancer immunotherapy revealed
Pharmaceutical Technology
NOVEMBER 7, 2023
GlobalData uncovers the leading innovators in cancer immunotherapy for the pharmaceutical industry.
Pfizer cost-savings campaign reaches Ireland, where 100 production workers will lose jobs
Fierce Pharma
NOVEMBER 7, 2023
Pfizer’s $3.5 billion cost-savings drive has made its way overseas. | The layoffs at Pfizer's Newbridge, Kildare, manufacturing site are the latest in the company's effort to save $3.5 billion by 2024 amid declining demand for its COVID-19 products.
The New Age of Decentralized Clinical Trials
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Leading innovators in transdermal drug delivery for the pharmaceutical industry
Pharmaceutical Technology
NOVEMBER 7, 2023
GlobalData uncovers the leading innovators in transdermal drug delivery for the pharmaceutical industry.
Frontiers Health 2023 Day One
pharmaphorum
NOVEMBER 7, 2023
Frontiers Health 23 - Day 1 from the marvellous Auditorium della Tecnica in Rome, where we are set to bring you the biggest news stories, trends, and industry insights
BIO-Europe 2023: Small oncology biotechs require creative financing approaches
Pharmaceutical Technology
NOVEMBER 7, 2023
At the BIO-Europe conference, experts said smaller oncology biotechs need to explore alternate financing strategies for pipeline development.
With Amgen's biosim on the scene, J&J's Stelara looks poised to sidestep Medicare negotiations: HHS
Fierce Pharma
NOVEMBER 7, 2023
There might just be a silver lining for Johnson & Johnson in the FDA's recent approval of Amgen’s Stelara biosimilar. | There might just be a silver lining for Johnson & Jonhson in the FDA's recent approval of Amgen’s Stelara biosimilar. That’s because the coming entry of a cheaper copycat presents J&J with an opportunity to elude Medicare price negotiations outlined in the Inflation Reduction Act.
Landmark Bio and Galapagos sign deal for oncology CAR-T cell therapy
Pharmaceutical Technology
NOVEMBER 7, 2023
Landmark Bio and Galapagos have signed an agreement for the manufacture of the latter’s oncology CAR T-cell therapy
The ‘elegant science’ in achieving the promise of ADCs
pharmaphorum
NOVEMBER 7, 2023
In this week’s episode of the pharmaphorum podcast, web editor Nicole Raleigh speaks with Raquel Izumi, chief operating officer and co-founder of Vincerx Pharma, who is on a mission to improve antibody drug conjugate (or ADC) drug development, aiming to conquer cancer with safe, well-tolerated, and paradigm-shifting therapeutics.
NICE introduces revamped support service for life sciences sector
Pharmaceutical Technology
NOVEMBER 7, 2023
The UK National Institute for Health and Care Excellence (NICE) unveils refreshed support service, NICE Advice, for the life sciences sector.
Bluebird won't play off Vertex in deciding price for its lovo-cel gene therapy, exec says
Fierce Pharma
NOVEMBER 7, 2023
Two long-awaited treatments for sickle cell disease (SCD) are on the docket for FDA decisions next month. Vertex and CRISPR Therapeutics are up first with a Dec. | Two long-awaited treatments for sickle cell disease (SCD) are on the docket for FDA decisions next month. One potential advantage for bluebird, giving the timing, could be a chance to view its rival's pricing before deciding itself.
The New Age of Decentralized Clinical Trials
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Leading innovators in nucleotide analogues for the pharmaceutical industry
Pharmaceutical Technology
NOVEMBER 7, 2023
GlobalData uncovers the leading innovators in nucleotide analogues for the pharmaceutical industry.
BioNTech flashes the cash, adding tumour drug in $1bn deal
pharmaphorum
NOVEMBER 7, 2023
BioNTech flashes the cash, adding tumour drug in $1bn deal Phil.
Leading innovators in SMAC mimetic peptides for the pharmaceutical industry
Pharmaceutical Technology
NOVEMBER 7, 2023
GlobalData uncovers the leading innovators in SMAC mimetic peptides for the pharmaceutical industry.
Health Innovators – Søren Møller
pharmaphorum
NOVEMBER 7, 2023
Søren Møller, managing partner for seed investments at Novo Holdings, has successfully supported numerous healthcare startups through strategic investments.
Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Genomics: the leading companies in anti-sense oligonucleotides revealed
Pharmaceutical Technology
NOVEMBER 7, 2023
GlobalData uncovers the leading innovators in anti-sense oligonucleotides for the pharmaceutical industry.
CARGO eyes $300m IPO against lacklustre listings backdrop
pharmaphorum
NOVEMBER 7, 2023
CARGO eyes $300m IPO against lacklustre listings backdrop Phil.
Leading innovators in T-cell binding fusion peptides for the pharmaceutical industry
Pharmaceutical Technology
NOVEMBER 7, 2023
GlobalData uncovers the leading innovators in T-cell binding fusion peptides for the pharmaceutical industry.
BREAKING: Breast cancer drug licensed as preventative measure
Outsourcing Pharma
NOVEMBER 7, 2023
A breast cancer drug that has been used for many years to treat the disease, has been licensed today (November 7) as a preventative measure.
How Machine Learning Drives Clinical Trial Efficiency
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Let's personalize your content